Free Trial

1,229,103 Shares in Colgate-Palmolive (NYSE:CL) Purchased by Castlekeep Investment Advisors LLC

Colgate-Palmolive logo with Consumer Staples background

Castlekeep Investment Advisors LLC acquired a new stake in Colgate-Palmolive (NYSE:CL - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 1,229,103 shares of the company's stock, valued at approximately $111,738,000. Castlekeep Investment Advisors LLC owned approximately 0.15% of Colgate-Palmolive at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Chicago Partners Investment Group LLC increased its holdings in shares of Colgate-Palmolive by 16.2% in the fourth quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company's stock valued at $591,000 after purchasing an additional 943 shares in the last quarter. Aviva PLC boosted its position in Colgate-Palmolive by 13.4% in the 4th quarter. Aviva PLC now owns 973,421 shares of the company's stock valued at $88,494,000 after buying an additional 114,855 shares during the last quarter. Peak Financial Advisors LLC acquired a new stake in shares of Colgate-Palmolive in the 4th quarter valued at $1,315,000. Fiduciary Alliance LLC bought a new stake in shares of Colgate-Palmolive during the fourth quarter worth $4,066,000. Finally, Impact Partnership Wealth LLC acquired a new position in shares of Colgate-Palmolive during the fourth quarter valued at $803,000. Institutional investors and hedge funds own 80.41% of the company's stock.

Analyst Upgrades and Downgrades

CL has been the subject of a number of research reports. StockNews.com upgraded Colgate-Palmolive from a "hold" rating to a "buy" rating in a research report on Tuesday, April 29th. Barclays dropped their price target on shares of Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating for the company in a research note on Friday, April 11th. JPMorgan Chase & Co. raised their price objective on shares of Colgate-Palmolive from $95.00 to $103.00 and gave the company an "overweight" rating in a research note on Monday, April 28th. TD Cowen dropped their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating for the company in a research report on Wednesday, January 8th. Finally, Morgan Stanley cut their price target on Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating on the stock in a research note on Monday, February 3rd. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $102.39.

Check Out Our Latest Report on CL

Colgate-Palmolive Price Performance

Shares of CL opened at $90.42 on Monday. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. The firm has a market capitalization of $73.28 billion, a PE ratio of 25.69, a P/E/G ratio of 4.20 and a beta of 0.40. The stock has a 50 day simple moving average of $92.26 and a 200 day simple moving average of $91.78. Colgate-Palmolive has a 52-week low of $85.32 and a 52-week high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings results on Friday, April 25th. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.86 by $0.05. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. The company had revenue of $4.91 billion during the quarter, compared to analysts' expectations of $4.92 billion. During the same quarter in the prior year, the company earned $0.86 earnings per share. The business's quarterly revenue was down 3.0% compared to the same quarter last year. Sell-side analysts predict that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Thursday, April 17th will be issued a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.30%. This is a positive change from Colgate-Palmolive's previous quarterly dividend of $0.50. The ex-dividend date is Thursday, April 17th. Colgate-Palmolive's payout ratio is 58.76%.

Colgate-Palmolive announced that its Board of Directors has initiated a share buyback plan on Thursday, March 20th that permits the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization permits the company to buy up to 6.8% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company's board believes its shares are undervalued.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Colgate-Palmolive Right Now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Sectors With Massive Momentum You Can’t Afford to Miss
Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential
Buy Early: 3 Tech Trends With Millionaire-Making Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines